Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
about
Weekly epirubicin in patients with hormone-resistant prostate cancer.TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy.SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.Cardiovascular complications of breast cancer therapy in older adultsContinuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac OutcomesDoxorubicin (adriamycin) cardiomyopathy.
P2860
Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
description
1980 nî lūn-bûn
@nan
1980 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Adriamycin given as a weekly s ...... d incidence of cardiotoxicity.
@ast
Adriamycin given as a weekly s ...... d incidence of cardiotoxicity.
@en
type
label
Adriamycin given as a weekly s ...... d incidence of cardiotoxicity.
@ast
Adriamycin given as a weekly s ...... d incidence of cardiotoxicity.
@en
prefLabel
Adriamycin given as a weekly s ...... d incidence of cardiotoxicity.
@ast
Adriamycin given as a weekly s ...... d incidence of cardiotoxicity.
@en
P2093
P1476
Adriamycin given as a weekly s ...... d incidence of cardiotoxicity.
@en
P2093
Bateman JR
Chlebowski RT
P577
1980-01-01T00:00:00Z